Commentary: Subthreshold micropulse yellow laser for central serous chorioretinopathy: Finding the right protocol
- PMID: 36018118
- PMCID: PMC9675504
- DOI: 10.4103/ijo.IJO_1461_22
Commentary: Subthreshold micropulse yellow laser for central serous chorioretinopathy: Finding the right protocol
Conflict of interest statement
None
Comment on
-
Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.Indian J Ophthalmol. 2022 Sep;70(9):3341-3345. doi: 10.4103/ijo.IJO_228_22. Indian J Ophthalmol. 2022. PMID: 36018117 Free PMC article.
References
-
- Moreno-Morillo FJ, Fernández-Vigo JI, Güemes-Villahoz N, Burgos-Blasco B, López-Guajardo L, Donate-López J. Update on the management of chronic central serous chorioretinopathy. Arch Soc Esp Oftalmol (Engl Ed) 2021;96:251–64. - PubMed
-
- Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy:One-year results of a prospective study. Retina. 2008;28:85–93. - PubMed
-
- van Dijk EH, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JM, Keunen JE, et al. Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy:The PLACE trial. Ophthalmology. 2018;125:1547–55. - PubMed
-
- Roca JA, Wu L, Fromow-Guerra J, Rodríguez FJ, Berrocal MH, Rojas S, et al. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy:Results of the Pan-American Collaborative Retina Study (PACORES) group. Br J Ophthalmol. 2018;102:1696–700. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
